Theodore DeWeese Appointed Vice Dean for Clinical Affairs

To the Johns Hopkins Medicine community

Dear Colleagues,

I am excited to announce that Theodore DeWeese will serve as the Johns Hopkins University School of Medicine vice dean for clinical affairs and president of the Clinical Practice Association, a group practice of our full-time clinical faculty and clinical associates. Dr. DeWeese, an internationally recognized radiation oncologist, the Sidney Kimmel Professor and director of radiation oncology and molecular radiation sciences, will succeed Bill Baumgartner, who is retiring as vice dean for clinical affairs after more than 35 years with Johns Hopkins.

Since coming to Johns Hopkins 27 years ago for a residency in radiation oncology, Dr. DeWeese has demonstrated a commitment to innovative and high-value patient care and expert research. He served as chief resident and completed a postdoctoral research fellowship at what is now the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and at the Brady Urological Institute in the early 1990s, then steadily climbed the academic ladder. He joined the school of medicine faculty in 1995 and was promoted to professor eight years later. His first leadership appointment was as director of the radiation biology laboratory research program for the Cancer Center from 2000 to 2003.

Recognized for his resourceful and collaborative leadership abilities, Dr. DeWeese became the founding director of the Department of Radiation Oncology and Molecular Radiation Sciences in 2003, and has built the program into one of the most successful and highly ranked programs in the United States. Throughout his tenure, he oversaw substantial growth in the clinical, research and training aspects of the department, including being the first department to integrate at both Sibley Memorial Hospital and Suburban Hospital beginning in 2011. He will continue to hold the department director position until Jan. 15, 2019.

Two years ago, when we sought to enhance our efforts to integrate patient care across the enterprise, Dr. DeWeese was tapped to serve as vice president for interdisciplinary patient care for Johns Hopkins Medicine. During that time, Dr. DeWeese and his team developed an interdisciplinary service line structure that has resulted in the creation of three interdisciplinary service lines in two years: musculoskeletal, which focuses on care for patients with knee and hip joint problems, as well as those with low back pain; solid organ transplant and transgender medicine.

With research interests that include prostate cancer, DNA damage repair, and the development of radio-sensitizing drugs and small molecules, Dr. DeWeese has published more than 170 papers and book chapters, and he has received numerous teaching awards and invitations to deliver named lectureships. He has served on several advisory boards, and was appointed by the National Academy of Sciences to serve as a scientific councilor for the Radiation Effects Research Foundation in Hiroshima, Japan. Dr. DeWeese has admirably served on and chaired many Johns Hopkins boards and committees, including Johns Hopkins Medicine's United Way campaign and the Johns Hopkins Hospital medical board. He is president-elect of the American Society for Radiation Oncology.

I am enormously appreciative of Dr. DeWeese's contributions to Johns Hopkins, and I look forward to working with him to advance Johns Hopkins Medicine. Please join me in congratulating him on this well-deserved appointment.

Sincerely,

Paul B. Rothman, M.D.
Dean of the Medical Faculty
CEO, Johns Hopkins Medicine